TSE:EXE Extendicare (EXE) Stock Price, News & Analysis → Big Tech is spending billions each month on Nvidia’s AI superproject (From Weiss Ratings) (Ad) Free EXE Stock Alerts C$7.48 +0.01 (+0.13%) (As of 06/12/2024 ET) Add Compare Share Share Today's RangeC$7.46▼C$7.5850-Day RangeC$7.24▼C$7.8752-Week RangeC$5.75▼C$8.04Volume65,456 shsAverage Volume130,609 shsMarket CapitalizationC$623.68 millionP/E Ratio18.24Dividend Yield6.42%Price TargetC$8.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Get Extendicare alerts: Email Address Extendicare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside11.4% UpsideC$8.33 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.53 out of 5 stars 2.3 Analyst's Opinion Consensus RatingExtendicare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageExtendicare has only been the subject of 2 research reports in the past 90 days.Read more about Extendicare's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EXE. Previous Next 1.7 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 6.44%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Extendicare is 117.07%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Extendicare's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXE. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 1 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 20.15% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is 18.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.86.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is 18.24, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 181.64.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 6.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Extendicare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsBig Tech is spending billions each month on Nvidia’s AI superprojectA small handful of Nvidia’s partners could see their own stocks surge upwards. They’re virtually unknown right now, but that won’t be the case much longer.Click here to find out who they are today. About Extendicare Stock (TSE:EXE)Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More EXE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXE Stock News HeadlinesMay 22, 2024 | msn.comDividend Investors Can Earn $500 Every Month or More With the Right Stock Offering a 6% YieldMay 6, 2024 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) a year ago are up 18%April 30, 2024 | finance.yahoo.comAlayaCare Selected by ParaMed as Technology Platform to Power Home Health Care Across CanadaApril 9, 2024 | theglobeandmail.comContra Guys: As seniors’ population rises, Extendicare worth a lookApril 8, 2024 | finance.yahoo.comCan Extendicare Inc. (TSE:EXE) Maintain Its Strong Returns?April 4, 2024 | theglobeandmail.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallApril 4, 2024 | finance.yahoo.comExtendicare Announces Timing of 2024 First Quarter Results and Conference CallMarch 20, 2024 | fool.caInvest $374.50 Each Month to Create Passive Income of $288 in 2024March 10, 2024 | seekingalpha.comExtendicare Inc. (EXETF) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Fourth Quarter and Year End ResultsMarch 8, 2024 | msn.comExtendicare GAAP EPS of C$0.10, revenue of C$350.18MFebruary 20, 2024 | finance.yahoo.comIs Now An Opportune Moment To Examine Extendicare Inc. (TSE:EXE)?February 15, 2024 | finance.yahoo.comExtendicare Opens the MarketJanuary 19, 2024 | finance.yahoo.comExtendicare Announces Timing of 2023 Fourth Quarter Results and Conference CallJanuary 15, 2024 | finance.yahoo.comExtendicare Announces January 2024 Dividend of C$0.04 per ShareDecember 23, 2023 | seekingalpha.comEXE:CA Extendicare Inc.December 15, 2023 | finance.yahoo.comExtendicare Announces December 2023 Dividend of C$0.04 per ShareNovember 9, 2023 | finance.yahoo.comExtendicare Announces 2023 Third Quarter ResultsOctober 19, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc flat on Thursday (EXE)October 16, 2023 | finance.yahoo.comExtendicare Announces October 2023 Dividend of C$0.04 per ShareOctober 11, 2023 | finance.yahoo.comExtendicare Inc.'s (TSE:EXE) Intrinsic Value Is Potentially 61% Above Its Share PriceSeptember 15, 2023 | finance.yahoo.comExtendicare Announces September 2023 Dividend of C$0.04 per ShareSeptember 14, 2023 | finanznachrichten.deExtendicare Inc: Extendicare Announces Closing of Transaction with AxiumSeptember 14, 2023 | finance.yahoo.comEXE.TO - Extendicare Inc.September 13, 2023 | theglobeandmail.comClosing Bell: Extendicare Inc 5 Pct Debs down on Wednesday (EXE-DB-C)See More Headlines Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/15 Dividend4/29/2024Last Earnings5/15/2024Dividend Payable5/15/2024Ex-Dividend for 6/17 Dividend5/31/2024Today6/13/2024Dividend Payable6/17/2024Next Earnings (Estimated)8/08/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price TargetC$8.33 High Stock Price TargetC$8.50 Low Stock Price TargetC$8.00 Potential Upside/Downside+11.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.41 Trailing P/E Ratio18.24 Forward P/E Ratio15.96 P/E GrowthN/ANet IncomeC$35.50 million Net Margins2.63% Pretax MarginN/A Return on Equity37.03% Return on Assets6.73% Debt Debt-to-Equity Ratio365.69 Current Ratio0.82 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.35 billion Price / Sales0.46 Cash FlowC$2.34 per share Price / Cash Flow3.20 Book ValueC$1.10 per share Price / Book6.80Miscellaneous Outstanding Shares83,380,000Free FloatN/AMarket CapC$623.68 million OptionableNot Optionable Beta1.23 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, President & Director Comp: $1.21MMr. David E. BaconSenior VP & CFOJoe BelinskyVP of Information Technology & Chief Information OfficerMs. Jillian E. FountainVice President of Investor RelationsMs. Kathryn Killoran BradleyVice President of Corporate DevelopmentMs. Katie LeMoyneSenior VP & Chief Human Resources OfficerMs. Wendy GilmourSenior Vice President of Long-term Care OperationsMs. Amie Cathleen VahrmeyerVice President of Long-Term Care Operations for ONMore ExecutivesKey CompetitorsdentalcorpTSE:DNTLSienna Senior LivingTSE:SIAWELL Health TechnologiesTSE:WELLMedical FacilitiesTSE:DRKDA GroupCVE:KDAView All Competitors EXE Stock Analysis - Frequently Asked Questions Should I buy or sell Extendicare stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EXE shares. View EXE analyst ratings or view top-rated stocks. What is Extendicare's stock price target for 2024? 4 Wall Street analysts have issued 1 year price targets for Extendicare's stock. Their EXE share price targets range from C$8.00 to C$8.50. On average, they expect the company's stock price to reach C$8.33 in the next year. This suggests a possible upside of 11.4% from the stock's current price. View analysts price targets for EXE or view top-rated stocks among Wall Street analysts. How have EXE shares performed in 2024? Extendicare's stock was trading at C$7.28 at the start of the year. Since then, EXE shares have increased by 2.7% and is now trading at C$7.48. View the best growth stocks for 2024 here. When is Extendicare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our EXE earnings forecast. How were Extendicare's earnings last quarter? Extendicare Inc. (TSE:EXE) announced its quarterly earnings results on Wednesday, May, 15th. The company reported $0.14 EPS for the quarter. The firm earned $367.10 million during the quarter, compared to analysts' expectations of $310 million. Extendicare had a net margin of 2.63% and a trailing twelve-month return on equity of 37.03%. How often does Extendicare pay dividends? What is the dividend yield for Extendicare? Extendicare declared a monthly dividend on Wednesday, May 15th. Stockholders of record on Friday, May 31st will be paid a dividend of 0.04 per share on Monday, June 17th. This represents a $0.48 annualized dividend and a dividend yield of 6.42%. The ex-dividend date is Friday, May 31st. Read our dividend analysis for EXE. Is Extendicare a good dividend stock? Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 6.44%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 117.07%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for EXE. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA). How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:EXE) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted t...Stansberry Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredInvest in the Firm Revolutionizing Brain HealthThey've engineered a patented transport vehicle that effectively "smuggles" drugs across the blood-brain barri...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.